Skip to main content

Table 2 Univariate and multivariate analysis for relapse-free survival (RFS) in stage III GC patients after curative gastrectomy followed by adjuvant chemotherapy

From: Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer

  Univariatea Multivariateb
  N 5-year RFSc P-value HRd 95% CIe P-value
Sex Male 61 46.1% 0.577 1.20 0.63–2.31 0.581
  Female 36 36.0%     
Age <65 46 42.2% 0.824 1.39 0.76–2.53 0.285
  ≥65 51 41.9%     
Tumor major axis(mm) ≥90 33 30.8% 0.092 1.46 0.71–3.21 0.109
  <90 64 48.8%     
T-stage T4 70 38.9% 0.326 1.46 0.79–3.63 0.311
  T2/ T3 27 50.1%     
N-stage N3 50 33.4% 0.339 1.51 0.82–2.84 0.187
  N1/ N2 47 50.9%     
Venous invasion Present 48 36.5% 0.034 1.82 1.01–3.37 0.048
  Absent 49 47.4%     
Lymphatic invasion Present 87 39.8% 0.168 1.51 0.56–5.28 0.445
  Absent 10 40.0%     
  1. aKaplan-Meier method: significance was determined by Wilcoxon test
  2. bMultivariate survival analysis was performed using Cox’s proportional hazard model
  3. cRFS Relative free survival
  4. dHR Hazard ratio
  5. eCI Confidence interval
  6. Significant values are in bold